LTGO
Latigo Biotherapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$15.54
−1.83%Latest reported
- Last report date
- Sep 3, 2026
- EPS actual
- -$0.65
- EPS estimate
- -$0.62
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -5.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 3, 2026 | -$0.62 | -$0.65 | Miss -5.40% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 3, 2026